相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China
Chenyang Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome
Cristian A. Carvajal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Clinical, Biochemical, and Genetic Characteristics of Nonclassic Apparent Mineralocorticoid Excess Syndrome
Alejandra Tapia-Castillo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Untargeted Metabolomics Provides insight into the Mechanisms Underlying Resistant Hypertension
Renata Wawrzyniak et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Circulating Plasma Metabolomic Profiles Differentiate Rodent Models of Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients
Jun-Han Zhao et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Downregulation of exosomal miR-192-5p and miR-204-5p in subjects with nonclassic apparent mineralocorticoid excess
Alejandra Tapia-Castillo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations
Alessandro Lana et al.
PROTEOMICS CLINICAL APPLICATIONS (2019)
Serum Cortisol and Cortisone as Potential Biomarkers of Partial 11β-Hydroxysteroid Dehydrogenase Type 2 Deficiency
Cristian A. Carvajal et al.
AMERICAN JOURNAL OF HYPERTENSION (2018)
The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor
Rene Baudrand et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies
David Broadhurst et al.
METABOLOMICS (2018)
Identification of essential hypertension biomarkers in human urine by non-targeted metabolomics based on UPLC-Q-TOF/MS
Huan Zhao et al.
CLINICA CHIMICA ACTA (2018)
Recent advances in the study of 11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2)Inhibitors
Chunchun Zhou et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2017)
Continuum of Renin-Independent Aldosteronism in Normotension
Rene Baudrand et al.
HYPERTENSION (2017)
Oxidative Stress, Inflammation, and Vascular Aging in Hypertension
Tomasz J. Guzik et al.
HYPERTENSION (2017)
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
Mabel Yau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension A Cohort Study
Jenifer M. Brown et al.
ANNALS OF INTERNAL MEDICINE (2017)
Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population
Setor K. Kunutsor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Discovery and Validation of Plasma Biomarkers for Major Depressive Disorder Classification Based on Liquid Chromatography-Mass Spectrometry
Xinyu Liu et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Mutagenicity of 5-Hydroxymethylfurfural in V79 Cells Expressing Human SULT1A1: Identification and Mass Spectrometric Quantification of DNA Adducts Formed
Bernhard H. Monien et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Metabolomics: the apogee of the omics trilogy
Gary J. Patti et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2
Xue Ma et al.
TOXICOLOGY (2011)
Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural
Nadiya Bakhiya et al.
BIOCHEMICAL PHARMACOLOGY (2009)
The Bilirubin Level is Negatively Correlated with the Incidence of Hypertension in Normotensive Korean Population
Ho Jun Chin et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
Endogenous inhibitors (GALFs) of 11β-hydroxysteroid dehydrogenase isoforms 1 and 2:: Derivatives of adrenally produced corticosterone and cortisol
D. J. Morris et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Alterations in mitochondrial and cytosolic methionine sulfoxide reductase activity during cardiac ischemia and reperfusion
Cedric R. Picot et al.
EXPERIMENTAL GERONTOLOGY (2006)
Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension
XS Min et al.
STRUCTURE (2004)
Two homozygous mutations in the 11β-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess
CA Carvajal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism
P Mulatero et al.
HYPERTENSION (2002)
Elevation in S-adenosylhomocysteine and DNA hypomethylation:: Potential epigenetic mechanism for homocysteine-related pathology
SJ James et al.
JOURNAL OF NUTRITION (2002)
The role of the 11 beta-hydroxysteroid dehydrogenase type 2 in human hypertension
P Ferrari et al.
JOURNAL OF HYPERTENSION (2000)
分享论文
